(Q24649935)
Statements
BIBW2992, an irreversible EGFR/HER2 inhibitor highly effective in preclinical lung cancer models (English)
0 references
7 August 2008
0 references
27
0 references
34
0 references
4702-11
0 references
1 reference
1 reference
1 reference
1 reference
1 reference